StatSure Diagnostic Systems manufactures and markets its patented point of care testing device for infectious diseases, as well as oral fluid specimen collection devices using a volume-adequacy indicator for drugs of abuse testing and other clinical uses. Certain of these products are sold in the United States as well as internationally to various distributors for use in clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations.
StatSure believes the underlying advantages of its format, rapid, safe, accurate and easy to read results, will capture a significant global market share of point-of-care screening in doctors’ offices, clinics, ERs and ultimately in self-testing by the consumer.
StatSure Diagnostic Systems’ primary business relates to a patented technology that provides point-of-care testing for certain infectious diseases. The company’s first commercial introduction of this platform is expected to be in screening for HIV antibodies. This funding will permit StatSure to commercialize its IP across a range of infectious disease testing opportunities beyond AIDS.
Recently StatSure signed a binding Term Sheet with Inverness Medical Innovations, Inc. (IMA), to develop and market consumer diagnostic products for HIV using StatSure’s patented “barrel” technology. IMA will receive an exclusive worldwide license for all consumer markets and a non-exclusive license to market the HIV barrel product to the professional markets. StatSure will be responsible for completing the development and for manufacturing the product.
StatSure Diagnostic Systems (SSUR) also announced that the company has successfully completed the sale of $2.15 million of its series 2006 A 8% convertible preferred stock to institutional investors. Chardan Capital Markets, LLC was the company’s placement agent for this transaction.
Sources:
Managed Care Weekly Digest
and
Statsure
Source:
StatSure Diagnostic Systems, Inc.
1 Clarks Hill Rd.
Framingham, MA 01702
Phone: 508-872-2625
Fax: 508-872-2728
http://www.statsurediagnostics.com
View the StockGuru Profile for StatSure Diagnostic Systems, Inc.:
http://www.stockguru.com/profiles/ssur/
About Statsure: SSUR develops rapid immunoassays for detecting antibodies to viruses and bacteria including HIV & H. pylori. It also makes specimen-collection devices (Saliva*Sampler and Omni-Swab) sold in the US; its Omni-SAL saliva-collection kit is sold in the UK. The Sero*Strip HIV test (approved by the World Health Organization), Hema*Strip HIV, and Saliva*Strip HIV tests detect HIV antibodies within minutes using patient serum, blood, or saliva. The serum and blood HIV tests are sold outside the US. Products are distributed through licensing agreements with other companies.
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 453-4268. Web: StockGuru.com. Email: Publisher@stockguru.com. Disclosure: Pentony Enterprises LLC was compensated $24,000 for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.